- Home
- WETH vs ESLA Comparison
WETH vs ESLA Comparison
Compare WETH & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WETH | ESLA |
|---|---|---|
| Founded | 1992 | 2021 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.9M | 19.1M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | WETH | ESLA |
|---|---|---|
| Price | $0.98 | $0.32 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 72.8K | ★ 209.7K |
| Earning Date | 11-11-2026 | 11-11-2026 |
| Dividend Yield | ★ 4.08% | N/A |
| EPS Growth | ★ 15.38 | N/A |
| EPS | ★ 0.50 | N/A |
| Revenue | ★ $45,136,818.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $1.96 | ★ N/A |
| Revenue Growth | ★ 6.76 | N/A |
| 52 Week Low | $0.91 | $0.30 |
| 52 Week High | $3.68 | $3.15 |
Technical Indicators
Market Signals| Indicator | WETH | ESLA |
|---|---|---|
| Relative Strength Index (RSI) | 41.26 | 17.30 |
| Support Level | $0.96 | N/A |
| Resistance Level | $1.27 | $0.51 |
| Average True Range (ATR) | 0.07 | 0.05 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 44.61 | 7.13 |
Price Performance
Historical ComparisonAbout WETH Wetouch Technology Inc.
Wetouch Technology Inc is a business of research and development, manufacturing, and distribution of touchscreen displays to customers both in the PRC and overseas. The touchscreen products, which are manufactured by the Company, are mainly for use in financial terminals, automotive, Point of Sales, gaming, lottery, medical, Human-Machine Interface (HMI), and other specialized industries. The company sells touchscreen products both domestically in China and internationally, covering areas in Mainland China, including but not limited to the eastern, southern, northern, and southwest regions of Mainland China, Taiwan, South Korea, Germany, and other countries.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.